Sanofi patents expiration

1. Renvela patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7985418 SANOFI Aliphatic amine polymer salts for tableting
Oct, 2025

(2 years from now)

Drugs and Companies using SEVELAMER CARBONATE ingredient

Market Authorisation Date: 19 October, 2007

Treatment: NA


How can I launch a generic of RENVELA before it's drug patent expiration?
More Information on Dosage

RENVELA family patents

Family Patents

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic